Literature DB >> 9242427

MCF-7: the first hormone-responsive breast cancer cell line.

A S Levenson1, V C Jordan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9242427

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  106 in total

1.  Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.

Authors:  G Castoria; M V Barone; M Di Domenico; A Bilancio; D Ametrano; A Migliaccio; F Auricchio
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.

Authors:  Brian J Park; Zakary L Whichard; Seth J Corey
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

3.  Effects of flutamide on [methyl-(3)h]-choline uptake in human prostate cancer-3 cells: a pilot study.

Authors:  Fatma Al-Saeedi
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

4.  Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.

Authors:  V Craig Jordan; Ramona Curpan; Philipp Y Maximov
Journal:  J Natl Cancer Inst       Date:  2015-04-02       Impact factor: 13.506

Review 5.  The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens.

Authors:  D A Tonetti; V C Jordan
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

6.  Establishment and characterization of a cell line (NABCA) derived from metastatic lymph nodes of breast scirrhous carcinoma.

Authors:  Satoshi Ohi; Shigeya Kyoda; Isao Tabei; Kouzou Ninomiya; Kayoko Sugiyama; Hisashi Hashimoto; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2006-11       Impact factor: 4.174

7.  The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.

Authors:  V Craig Jordan; Ifeyinwa Obiorah; Ping Fan; Helen R Kim; Eric Ariazi; Heather Cunliffe; Hiltrud Brauch
Journal:  Breast       Date:  2011-10       Impact factor: 4.380

8.  Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.

Authors:  Sreeharsha Gurrapu; Emanuela Pupo; Giulia Franzolin; Letizia Lanzetti; Luca Tamagnone
Journal:  Cell Death Differ       Date:  2018-03-19       Impact factor: 15.828

9.  Role of SP transcription factors in hormone-dependent modulation of genes in MCF-7 breast cancer cells: microarray and RNA interference studies.

Authors:  Fei Wu; Ivan Ivanov; Rui Xu; Stephen Safe
Journal:  J Mol Endocrinol       Date:  2008-10-24       Impact factor: 5.098

10.  Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation.

Authors:  Ulrike Bruning; Francisco Morales-Rodriguez; Joanna Kalucka; Jermaine Goveia; Federico Taverna; Karla C S Queiroz; Charlotte Dubois; Anna Rita Cantelmo; Rongyuan Chen; Stefan Loroch; Evy Timmerman; Vanessa Caixeta; Katarzyna Bloch; Lena-Christin Conradi; Lucas Treps; An Staes; Kris Gevaert; Andrew Tee; Mieke Dewerchin; Clay F Semenkovich; Francis Impens; Birgit Schilling; Eric Verdin; Johannes V Swinnen; Jordan L Meier; Rhushikesh A Kulkarni; Albert Sickmann; Bart Ghesquière; Luc Schoonjans; Xuri Li; Massimiliano Mazzone; Peter Carmeliet
Journal:  Cell Metab       Date:  2018-08-23       Impact factor: 27.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.